P.O. Box 94
Telephone +41 41 3690 300
Medical questions or adverse event reports can be directed to Amgen Medical Information.
For product questions or to report an adverse event or safety related issue, or to report a quality issue with a product or device:
Call +1 800-772-6436 (800-77-AMGEN) or +1 805-447-3505
If you are based outside of the US please click here for local contact information.
On November 21, 2019, Amgen acquired from Celgene Corporation the worldwide rights to Otezla® (apremilast).